Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Revive Therapeutics Ltd. C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for rare disorders and infectious diseases. The Company is exploring the use of Bucillamine for the treatment of infectious diseases, with an initial focus on severe influenza and COVID-19. Through its subsidiary, Psilocin Pharma Corp., the Company is advancing the development of Psilocybin-based therapeutics in various diseases and disorders. The Company’s cannabinoid pharmaceutical portfolio focuses on rare inflammatory diseases and the Company was granted Food and Drug Administration (FDA) orphan drug status designation for the use of Cannabidiol (CBD) to treat autoimmune hepatitis (liver disease) and to treat ischemia and reperfusion injury from organ transplantation.


CSE:RVV - Post by User

Comment by Imarunawayon Dec 11, 2020 8:07pm
83 Views
Post# 32091695

RE:RE:RE:RE:RE:RE:RE:Um hm statement of the obvious

RE:RE:RE:RE:RE:RE:RE:Um hm statement of the obviousTrue that Mike I don't think we will see as big a fall out as we had in the MJ legaization in Canada. A lot of that was due to the MJ Companies had enormous overhead and expenses to produce, distribute etc and only a small few are even still turning a profit. Mushrooms in Comparison are pretty cheap to produce and not in need of the same type elaborate facilities needed so as not to lose a crop due to infestation, air temp, nutes etc. It's a fungi and fairly easy to replicate many I know do it now at home for recreation and micro dosing. But most are happy to purchase to assure proper dosing and advice for their given condition. I could be wrong but I don't suspect the same fall out given my knowledge and experience. The other side is some Dr.'s  are in line to try before prescribing which is huge and not the footprint I have seen thus far for M.J. Not to mention bucillamine, cbd's etc are a throw in on this stock. Thoughts?
<< Previous
Bullboard Posts
Next >>